EWTX
Edgewise Therapeutics, Inc.Marquee-fund ownership over time
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $17 | $32 | +86% |
| Two Sigma Investments re-entered | Q3 2024(8Q snapshot) | 7Q | $17 | $32 | +86% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $17 | $32 | +86% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $17 | $32 | +86% |
| AQR Capital Management re-entered | Q4 2024(8Q snapshot) | 6Q | $33 | $32 | -3% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Viking Global Investors | Q2 2021 | Q3 2025 | → $14 | -48% |
| Point72 Asset Management | Q1 2025 | Q2 2025 | → $14 | -43% |
| Renaissance Technologies | Q4 2024 | Q1 2025 | → $26 | -22% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Edgewise Therapeutics, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from May 5, 2026 — the most recent Form 4 on file — not from today.
- Form 40001644087-26-000004May 5, 2026
- Form 40001655016-26-000002Apr 3, 2026
- Form 40001644087-26-000003Apr 2, 2026
- Form 40001644087-26-000002Mar 31, 2026
- Form 40001644087-26-000001Mar 30, 2026
- Form 40001786966-26-000001Jan 23, 2026
- Form 40001655016-26-000001Jan 5, 2026
- Form 40002097992-25-000005Nov 24, 2025
- Form 40001853529-25-000007Nov 13, 2025
- Form 40001655016-25-000007Nov 13, 2025
- Form 40001705477-25-000005Nov 13, 2025
- Form 40001655016-25-000004Oct 2, 2025
- Form 40001853529-25-000003Aug 28, 2025
- Form 40001562180-25-005800Aug 14, 2025
- Form 40001562180-25-005799Aug 14, 2025
Fundamentals
XBRL · Edgewise Therapeutics, Inc.Annual figures sourced directly from Edgewise Therapeutics, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Edgewise Therapeutics, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KFORM 8-KJun 5, 2026
- 8-KMaterial eventJun 1, 2026
- 8-KFORM 8-KMay 7, 2026
- 10-QQuarterly reportMay 7, 2026
- DEF 14AProxy statementApr 23, 2026
- 10-KAnnual reportFeb 26, 2026
- 8-KFORM 8-KFeb 26, 2026
- 8-KFORM 8-KNov 20, 2025
- 8-KFORM 8-KNov 10, 2025
- 10-QQuarterly reportNov 6, 2025
- 8-KFORM 8-KNov 6, 2025
- 10-QQuarterly reportAug 7, 2025
- 8-KFORM 8-KAug 7, 2025
- 8-KFORM 8-KJun 26, 2025
- 10-QQuarterly reportMay 8, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| AQR Capital Management | Q1 2026 | open | $30 | $32 | +5% |
| Two Sigma Investments | Q4 2025 | open | $23 | $32 | +39% |
| Point72 Asset Management | Q1 2025 | Q2 2025 | $25 | $14 | -43% |
| AQR Capital Management | Q4 2024 | Q3 2025 | $33 | $14 | -58% |
| Renaissance Technologies | Q4 2024 | Q1 2025 | $33 | $26 | -22% |
| Citadel Advisors | Q3 2024 | open | $17 | $32 | +86% |
| Two Sigma Investments | Q3 2024 | Q3 2025 | $17 | $14 | -18% |
| D.E. Shaw | Q3 2024 | open | $17 | $32 | +86% |
| Millennium Management | Q3 2024 | open | $17 | $32 | +86% |
| Viking Global Investors | Q2 2021 | Q3 2025 | $27 | $14 | -48% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.